CXCL13 is a plasma biomarker of germinal center activity. - Wikidata - wikimedia - TriplyDB

CXCL13 is a plasma biomarker of germinal center activity.

CXCL13 is a plasma biomarker of germinal center activity.

http://www.wikidata.org/entity/Q36684710

about

A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Lower Baseline Germinal Center Activity and Preserved Th1 Immunity Are Associated With Hepatitis B Vaccine Response in Treated HIV Infection.Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer.A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.CD4 T Follicular Helper Cells and HIV Infection: Friends or Enemies?Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation.CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses.Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.Functional RNAs control T follicular helper cells.Approaches to the induction of HIV broadly neutralizing antibodies.Implications of Intravital Imaging of Murine Germinal Centers on the Control of B Cell Selection and Division.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.Adjuvants: tailoring humoral immune responses.Differences in Tfh Cell Response Between the Graft and Spleen With Chronic Allograft Nephropathy.T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART.A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood.Vaccination establishes clonal relatives of germinal center T cells in the blood of humans.Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV.Chronic HIV-1 Infection Impairs Superantigen-Induced Activation of Peripheral CD4+CXCR5+PD-1+ Cells, With Relative Preservation of Recall Antigen-Specific Responses.Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies.Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells.T Follicular Helper Cells As a New Target for Immunosuppressive Therapies.Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells.B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection.Epstein-Barr Virus, but Not Cytomegalovirus, Latency Accelerates the Decay of Childhood Measles and Rubella Vaccine Responses-A 10-Year Follow-up of a Swedish Birth Cohort.Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination.Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function.Early B cell changes predict autoimmunity following combination immune checkpoint blockade.Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes.HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.

P2860

Q30234577-D5C8A86A-CA8C-4348-949C-FCA69C8333D2 Q33745613-D07230C9-308B-408B-A8DD-68ED63188558 Q33850577-C052608C-2ECF-4E5F-A6AF-CEF86C94EDD1 Q33867299-B931A17A-56DE-4810-9A16-E476AEC99BEA Q37409268-2F97B115-D3FA-4FB4-A471-92D68B788D6D Q37482035-30EE2DDA-682F-4386-9715-8B893D644A8C Q37593174-E82CE260-AF23-4DAE-B448-574253014FAD Q37634061-DB4F582B-2C98-48FD-9CB6-2C992733A9D6 Q37651727-2B84A7EE-235F-4FB3-BC04-EECBADFEB6A4 Q38636875-836C1038-9D2F-4B5E-BD64-1169483C48A2 Q38751056-13F36897-9697-4C44-A13A-86D3B105AFFB Q38774904-27F0FE27-B22B-4210-86BB-B7416A307A02 Q38786915-3832AADE-DCBD-47AD-841D-426B2E06DF03 Q38825796-F59CC408-030C-41BB-9B56-F6F7D2E25760 Q38862338-B1A10294-413C-442D-97E5-0BEC3B7EF990 Q38917576-E75EA72A-7A3B-4F2A-9EEB-1F58D4E5FBE2 Q38936867-AE652654-8976-471D-90CD-42B1276536A5 Q39032838-96A28A64-4027-4815-824C-02C8E208E1DD Q39108730-D141D4EC-7C1E-4E83-9B56-DC69D174DEED Q39108760-C665D3CB-5EAC-4CF8-B181-43E3E100016C Q39160011-D591A3F5-3C93-4760-AA4E-DEF849650F5F Q39490331-F5A6FD70-1096-4780-A407-FFA95F1A337E Q40075952-91330433-5C2F-4F8E-98A7-730EE1ED2F24 Q40099738-3A745CDD-6B40-4D7D-8403-4B36B500267B Q40163107-44A5DC33-972C-4534-9554-6F912A5A8A4F Q40346802-3A5F7672-C9B3-4675-B49C-DAF897365711 Q40581381-4EC6ADEA-5AD7-47E3-B8C2-391929ACC1E2 Q40639803-BB0EE602-C808-4FCD-AF58-661FC6FF6F09 Q41699538-EE91547A-C7A7-4ED8-9EB5-54CC3028D3C6 Q46051918-C5563DC0-5EBD-47CC-BCFE-425C59D40E87 Q47109235-CBA899A7-358E-435B-9758-229BE3F7DC75 Q47112853-C701EBBE-0F63-4A17-931E-C924E2042646 Q47169594-9D46F9E0-866A-4188-9803-8C3D9506B71E Q47267247-40A66FE2-13BC-43D1-B716-4359B664278B Q47315452-8142CB71-91C7-48B1-993D-B26213B496B3 Q47548910-28D12B13-334B-4929-84BD-69C1344E1089 Q48248992-878CC24B-780C-4545-ACB6-4E991043B3F6 Q50140526-C1CC2B4D-416E-4DE8-BD4B-239E402A6379 Q50146914-3737F26A-5434-4952-A48F-B44C23185363 Q52598776-9C92248A-2156-4C0C-A85A-B708814A766E

P2860

CXCL13 is a plasma biomarker of germinal center activity.

http://www.wikidata.org/entity/Q36684710

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CXCL13 is a plasma biomarker of germinal center activity.

@ast

CXCL13 is a plasma biomarker of germinal center activity.

@en

type

label

CXCL13 is a plasma biomarker of germinal center activity.

@ast

CXCL13 is a plasma biomarker of germinal center activity.

@en

prefLabel

CXCL13 is a plasma biomarker of germinal center activity.

@ast

CXCL13 is a plasma biomarker of germinal center activity.

@en

P1433

Q36684710-848DB622-5679-4FB7-BC01-6BCA96092DD6

P1476

Q36684710-52B849D9-744C-4FFB-BEB2-3F7CEDF5C98F

P2093

Q36684710-033967C1-2C81-457E-A102-1ED7E972D4DB

Q36684710-44803067-C6D0-4380-AF47-39DBD4C4D5C1

Q36684710-49F5A88F-0A6D-418E-B05A-1F1E8F70AF76

Q36684710-5542A7A0-DD47-4147-9E7A-B8B220A712F2

Q36684710-56FA4E18-C13C-420F-BA61-C69A2588E845

Q36684710-5F6989C3-97D3-4B77-932E-8585239970E6

Q36684710-72E0E93B-DB01-4E0F-B12D-D2A4A59AD064

Q36684710-7B473D66-4D22-4041-A266-231E1A962240

Q36684710-88870363-CCB4-414E-BE83-4A5395452BE7

Q36684710-88BE3D1F-4AA6-4CF0-B591-9347DE82A1A9

P2860

Q36684710-028F64C7-A3A7-4232-B8EA-AAD66EDD7443

Q36684710-038D09EE-D55C-4F78-8F56-0F0919433310

Q36684710-0A387305-9229-43B0-9981-1B1B8EA24E6A

Q36684710-17943527-D704-4264-AD9F-FFE362FF646C

Q36684710-1FBE63AE-6EE5-4470-B33E-92C54F768805

Q36684710-27A26B3B-3B00-4F6F-B04E-87D83A7775E6

Q36684710-2A45C224-CD22-45A3-B961-7784E9C29593

Q36684710-2E205373-C909-4457-9666-338E3DCA697C

Q36684710-2EE9F8A5-B8E7-494E-8545-0972B18DD8B1

Q36684710-2F611353-8D58-469E-A222-63871CF63F6E

P304

Q36684710-01E3AB59-8854-4B18-9284-7567D413192B

P31

Q36684710-983BDD88-2076-4272-AD32-314971ACD696

P356

Q36684710-4C46B06F-39FE-4C0B-8927-69C6DDB63DB8

P407

Q36684710-FDD4A5FF-0B96-4298-A870-BB7EE076815C

P433

Q36684710-AE41C94A-225B-40FF-BD3F-A0284488E106

P478

Q36684710-4F108C0D-A9C2-41B0-83B4-443303F6ADF1

P50

Q36684710-174C43DF-D55C-4A4B-BC38-50A7E26BCFFE

Q36684710-5DF7F96F-797B-496F-A317-FF042AA88D1D

Q36684710-7ADE44ED-88BF-460B-930C-D5BD8E412A3F

Q36684710-B9E772B7-E640-482F-B8BC-7100CE8DD1DC

Q36684710-BCF7E600-CE12-43C3-894D-849950C56D12

Q36684710-BCFB7183-2CDF-45A0-BF37-D28FB080A812

P577

Q36684710-372DFA41-6436-4C91-8D1B-89933D1A6FA8

P5875

Q36684710-5665865E-C633-49D0-83EC-83598FD86CE4

P698

Q36684710-9F3B83FA-511B-440F-AF67-6AF7B27ACA48

P921

Q36684710-173BDF97-2D4E-409F-9874-ADD1A611F685

P932

Q36684710-0D09388C-1026-4681-ACC0-550CCDB2A0CD

P356

PNAS.1520112113

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

CXCL13 is a plasma biomarker of germinal center activity.

@en

P2093

Antje Heit

http://www.w3.org/2001/XMLSchema#string

Bali Pulendran

http://www.w3.org/2001/XMLSchema#string

Daniel E Kaufmann

http://www.w3.org/2001/XMLSchema#string

Eileen Scully

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Helen M McGuire

http://www.w3.org/2001/XMLSchema#string

IAVI Protocol C Principal Investigators

http://www.w3.org/2001/XMLSchema#string

Jennifer E Wu

http://www.w3.org/2001/XMLSchema#string

Kayla Kendric

http://www.w3.org/2001/XMLSchema#string

Madelene Lindqvist

http://www.w3.org/2001/XMLSchema#string

P2860

A Blueprint for HIV Vaccine Discovery

Antibody responses to envelope glycoproteins in HIV-1 infection

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

Progress in HIV-1 vaccine development.

A chemokine-driven positive feedback loop organizes lymphoid follicles

Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation

HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers

Programming the magnitude and persistence of antibody responses with innate immunity.

Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter.

P304

2702-2707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1520112113

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Walker

Colin Havenar-Daughton

Pascal Poignard

P577

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295832101

http://www.w3.org/2001/XMLSchema#string

P698

26908875

http://www.w3.org/2001/XMLSchema#string

P921

P932

4790995

http://www.w3.org/2001/XMLSchema#string